Outcomes following Serial Intragastric Balloon Therapy for Obesity and Nonalcoholic Fatty Liver Disease in a Single Centre.
Vi NguyenJiawei LiJaslyn GanPaul CorderoShuvra RayAlessandro Solis-CuevasMai KhatibJude A ObenPublished in: Canadian journal of gastroenterology & hepatology (2017)
IGB therapy is an effective, alternative nonsurgical means for weight loss in the management of obesity and NAFLD over the short term, with greatest outcomes observed after six months. Improvements in insulin resistance and hepatic transaminases correlated with weight change.
Keyphrases
- weight loss
- insulin resistance
- bariatric surgery
- roux en y gastric bypass
- metabolic syndrome
- high fat diet induced
- glycemic control
- gastric bypass
- weight gain
- type diabetes
- adipose tissue
- high fat diet
- skeletal muscle
- polycystic ovary syndrome
- obese patients
- mesenchymal stem cells
- stem cells
- cell therapy
- smoking cessation